# Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)

> **NCT01420432** · PHASE1 · UNKNOWN · sponsor: **Shandong University** · enrollment: 10 (estimated)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **BIOLOGICAL:** Human umbilical cord-derived MSCs

## Key facts

- **NCT ID:** NCT01420432
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01420432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01420432, "Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01420432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*